Navigation Links
Pharmacyclics, Inc. Rights Offering Oversubscribed
Date:8/5/2009

p>"We are delighted with the results of our recent rights offering," said Bob Duggan, Chairman and Chief Executive Officer of Pharmacyclics. "The rights offering offered our stockholders an opportunity to participate in the future of this Company, which is developing what we believe are differentiated products in the areas of oncology and autoimmune diseases. With the announcement of today's offering, we have the capital to drive our programs forward, particularly PCI 32765, our novel BTK Inhibitor, and PCI 24783, our Factor VIIa Inhibitor, to several inflection points. We are committed to driving shareholder value and look forward to updating you on our progress as we continue to produce important clinical results in the future."

Subscription rights that were not exercised by July 31, 2009 have expired.

About Pharmacyclics

Pharmacyclics((R)) is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative small-molecule drugs for the treatment of immune mediated disease and cancer. The purpose of the company is to create a profitable business by generating income from products it develops, licenses and commercializes, either with one or several potential partners or alone as may best forward the economic interest of its stakeholders. The Company endeavors to create novel, patentable, differentiated products that have the potential to significantly improve the standard of care in the markets it serves. Presently, Pharmacyclics has four product candidates in clinical development and two product candidates in pre-clinical development. It is Pharmacyclics' business strategy to establish collaborations with large pharmaceutical and biotechnology companies for the purpose of generating present and future income in exchange for adding to their product pipelines. Pharmacyclics strives to generate collaborations that allow it to retain valuable territorial rights and simultaneously fast
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Pharmacyclics Announces Subscription Price for Rights Offering
2. Pharmacyclics Files Registration Statement for Rights Offering
3. NovImmune Completes CHF 62.5 (USD 54.8) Million Equity Financing to Move Portfolio Forward and Reacquire Product Rights to Lead Antibodies
4. Sinobiopharma Secures Rights to Seven Key Patents
5. Samtheo Announces License Agreement with Moffitt Cancer Center for Exclusive Rights to Novel Akt Inhibitor
6. Micromet, Inc. To Regain Rights to Blinatumomab in North America; Reports Financial Results for the Fourth Quarter and Full Year ended December 31, 2008
7. Cephalon Exercises Option to License Worldwide Rights to ImmuPharma Product, Lupuzor
8. Valerie DeFillipo, Reproductive Health and Rights Expert, Joins Abt Associates
9. Senetek PLC Acquires Rights to Additional Anticancer RNAi Technology
10. Azur Pharma Ltd. Enters Into Definitive Agreement With BioSante Pharmaceuticals Inc [nasdaq: BPAX], to Acquire U.S. Rights to Elestrin (TM)
11. China Sky One Medical, Inc. Obtains Production Rights for Nine New Drugs

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)... , BETHESDA, Md., Nov. 19 /PRNewswire-FirstCal...novator in biotechnology for diabetes therapy, and... services to food, supplement, biotechnology and p...ts of Tuesday,s Annual Meeting of Shareholders. ,...orated (Nasdaq: SPEX ) elected the following memb...
(Date:11/19/2009)... , MUNSTER, Germany, November 19 /PRNew...y have filed on November 16th, 2009 Flibanserin in...d dyskinesia in Parkinson,s,disease for orphan dru...gency,(EMEA). Levodopa-induced dyskinesia is a com...rkinson,s and a serious burden to some of those,af...
(Date:11/19/2009)... Top LASIK surgeons and recog...ed at Trusted LASIK Surgeons made brought their fe...s in vision correction surgery, cataract surgery, ...uded American Academy of Ophthalmology (AAO) annua...d Lindstrom, Dr. Shachar Tauber, Dr. David Huang, ...
(Date:11/19/2009)... InSound is honored by latest... Newark, CA (PRWEB) November 16, 200...“invisible” hearing aid from InSound M...s New Award in the Health category.  &nb...is designed to reside deep in the hearing canal fo...
Breaking Biology Technology:Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 2Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 3Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 4Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 5Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 6Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 7Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 8Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 9Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 3
... With the price of soybean seed...ot;the sweet spot" - the ideal combination of...education director of the North Central Soybean Re...maximize soybean yield and profit potential in 200...EB) February 25, 2009 -- Optimal soybean planting ...
...RISBANE, Australia and SEATTLE, Feb. 24 Implicit,...the clinical-stage,monoclonal antibody IC14 from E...osed consideration combining cash and stock to Lil...14 sales. , "Implicit Bioscience brings substa...tients with immune-mediated disease," commented Pr...
...ALE, N.J., Feb. 24 Synvista Therapeutics, Inc. (...as entered into agreements with the current holder... per share, under which $2,875,000 in accrued divi...d Stock as of December 31, 2008 has been converted...ears from the date of issuance. Interest at the r...
Other Biology Technology:NCSRP Research Director: "Earlier Planting can Increase Soybean Yields" 2NCSRP Research Director: "Earlier Planting can Increase Soybean Yields" 3Implicit Licenses Clinical Stage Antibody Program From Lilly 2Implicit Licenses Clinical Stage Antibody Program From Lilly 3Synvista Therapeutics Announces Restructuring of Dividend Obligation to Preferred Stockholders and Decision to Delist from NYSE Alternext and Terminate SEC Registration of Common Stock 2Synvista Therapeutics Announces Restructuring of Dividend Obligation to Preferred Stockholders and Decision to Delist from NYSE Alternext and Terminate SEC Registration of Common Stock 3Synvista Therapeutics Announces Restructuring of Dividend Obligation to Preferred Stockholders and Decision to Delist from NYSE Alternext and Terminate SEC Registration of Common Stock 4
(Date:11/19/2009)...000 years ago, at the end of the last ice age, Nor...luding such iconic creatures as mammoths, mastodon... began their precipitous slide to extinction. , ...nd whose diversity of large animals equaled or sur...n or now, an entirely novel ecosystem emerged as b...
(Date:11/19/2009)...r, NY A four-year, multi-institutional effort co-...scientists culminated today in publication of a la...evealing in unprecedented detail the DNA sequence ...mmonly called by North American consumers, is one ...valuable agricultural crop grown in the United Sta...
(Date:11/19/2009)...tate,s Ross Hardison, T. Ming Chu Professor of Bio... step toward unraveling how regulatory proteins co...opment and growth. Working with collaborators incl...ren,s Hospital of Philadelphia, they focused speci...ood cells (erythrocytes). These cells contain larg...
Breaking Biology News(10 mins):After mastodons and mammoths, a transformed landscape 2After mastodons and mammoths, a transformed landscape 3Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 2Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 3Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 4New research into the mechanisms of gene regulation 2New research into the mechanisms of gene regulation 3New research into the mechanisms of gene regulation 4New research into the mechanisms of gene regulation 5URL Pharma Acquires PharmPro Manufacturing Facility and Equipment 53460 1URL Pharma Acquires PharmPro Manufacturing Facility and Equipment 53460 2SLAICO Takes the Medicare Supplement Application Online Eliminating All Paperwork Offline 53455 1SLAICO Takes the Medicare Supplement Application Online Eliminating All Paperwork Offline 53455 2Patients Issue Summer Call to Action 3A We Need You to Donate Blood NOW 53450 1Patients Issue Summer Call to Action 3A We Need You to Donate Blood NOW 53450 2Patients Issue Summer Call to Action 3A We Need You to Donate Blood NOW 53450 3
...October 23, 2008 -- Are green schools acoustically...? How can we protect manatees from getting hit by ..., Hindi, and Arabic languages reveal? Can we detec...er? What is the effect of noise in the home? How d...of the many questions that will be addressed at th...
...pany to Maintain and Enhance the Biometrics Automa...Va., Oct. 23 Science,Applications International C...en awarded a task order by the U.S. Army Program E...PEO-EIS) to provide engineering support to,help ma...t - Army (BAT-A),system. The task order has a one-...
...TA CLARA, Calif., Oct. 23 Synaptics,(Nasdaq: SYN...ons for mobile,computing, communications, and ente...s for the first quarter ended September 30, 2008. ...f non-cash share-based,compensation for all period...f fiscal 2009 was $115.9 million, an,increase of a...
Other Biology News:156th Acoustical Society of America Meeting, Nov. 10-14, 2008 in Miami 2156th Acoustical Society of America Meeting, Nov. 10-14, 2008 in Miami 3156th Acoustical Society of America Meeting, Nov. 10-14, 2008 in Miami 4156th Acoustical Society of America Meeting, Nov. 10-14, 2008 in Miami 5156th Acoustical Society of America Meeting, Nov. 10-14, 2008 in Miami 6156th Acoustical Society of America Meeting, Nov. 10-14, 2008 in Miami 7SAIC Awarded $37 Million Contract to Support U.S. Army Program Executive Office - Enterprise Information Systems 2Synaptics Reports Record Results for First Quarter of Fiscal 2009 2Synaptics Reports Record Results for First Quarter of Fiscal 2009 3Synaptics Reports Record Results for First Quarter of Fiscal 2009 4Synaptics Reports Record Results for First Quarter of Fiscal 2009 5Synaptics Reports Record Results for First Quarter of Fiscal 2009 6Synaptics Reports Record Results for First Quarter of Fiscal 2009 7Synaptics Reports Record Results for First Quarter of Fiscal 2009 8
BD Falcon Roller Bottle, smooth surface from BD Biosciences - Discovery Labware
...pecifically designed to target and display recombi...visiae. Displayed proteins can be analyzed for the...nds. pYD1 uses the a-agglutinin yeast adhesion rec..., to display recombinant protein on the surface of...
... heterologous protein expression in the Drosophil...derived from a primary culture of late stage (20-2.... This versatile cell line grows rapidly at room ...uspension culture. S2 cells are available frozen ...
Phenol Red, Free Acid from USB Corp.
Biology Products: